Abstract
Both carcinoid tumor (carcinoid) and neuroendocrine carcinoma (NEC) are composed of neuroendocrine cells which are positive for chromogranin. The former is a low grade malignancy but NEC is a highly aggressive malignancy. We compared histological differences of those tumors using antibodies to major histocompatibility complex (MHC) class II antigens HLA-DR, proliferating cell nuclear antigen (PCNA), Leu7 (CD57), CEA and P53. Most characteristic differences between those tumors were in the expression of HLA-DR and PCNA. HLA-DR positive capillary endothelial cells were abundant in carcinoid as well as in non-tumorous endocrine organs but sparse in NEC. On the contrary, cells positive for PCNA were 92% in NEC, but 27% in carcinoid. We concluded that carcinoid imitates an endocrine organ in both morphology and function, but NEC deviates far from it.
MeSH terms
-
Antigens, CD / analysis
-
Antigens, Differentiation, T-Lymphocyte / analysis
-
Antigens, Neoplasm / analysis
-
Biomarkers, Tumor / analysis*
-
CD57 Antigens
-
Carcinoembryonic Antigen / analysis
-
Carcinoid Tumor / pathology*
-
Carcinoid Tumor / surgery
-
Carcinoma / pathology*
-
Carcinoma / surgery
-
Female
-
Gallbladder Neoplasms / pathology
-
HLA-DR Antigens / analysis*
-
HLA-DR Antigens / biosynthesis
-
Humans
-
Liver Neoplasms / pathology
-
Lung Neoplasms / pathology
-
Male
-
Neoplasm Metastasis
-
Nuclear Proteins / analysis*
-
Nuclear Proteins / biosynthesis
-
Proliferating Cell Nuclear Antigen
-
Stomach Neoplasms / pathology
-
Tumor Suppressor Protein p53 / analysis
Substances
-
Antigens, CD
-
Antigens, Differentiation, T-Lymphocyte
-
Antigens, Neoplasm
-
Biomarkers, Tumor
-
CD57 Antigens
-
Carcinoembryonic Antigen
-
HLA-DR Antigens
-
Nuclear Proteins
-
Proliferating Cell Nuclear Antigen
-
Tumor Suppressor Protein p53